|
🐜
|
Prognostic value of microvascular obstruction and infarct size, as measured by CMR in STEMI patients.
20 auth.
Matthijs van Kranenburg,
M. Magro,
H. Thiele,
S. de Waha,
I. Eitel,
A. Cochet,
Y. Cottin,
D. Atar,
P. Buser,
E. Wu,
...
Daniel C. Lee,
V. Bodí,
G. Klug,
B. Metzler,
R. Delewi,
P. Bernhardt,
W. Rottbauer,
E. Boersma,
F. Zijlstra,
R. V. van Geuns
|
8 |
2014 |
8
🐜
|
|
🐜
|
[18F]FDG-PET predicts complete pathological response of breast cancer to neoadjuvant chemotherapy
10 auth.
A. Berriolo-Riedinger,
C. Touzery,
J. Riedinger,
M. Toubeau,
B. Coudert,
L. Arnould,
...
C. Boichot,
A. Cochet,
P. Fumoleau,
F. Brunotte
|
7 |
2007 |
7
🐜
|
|
🐜
|
Predictive value for disease progression of serum thyroglobulin levels measured in the postoperative period and after (131)I ablation therapy in patients with differentiated thyroid cancer.
10 auth.
M. Toubeau,
C. Touzery,
P. Arveux,
G. Chaplain,
G. Vaillant,
A. Berriolo,
...
J. Riedinger,
C. Boichot,
A. Cochet,
F. Brunotte
|
7 |
2004 |
7
🐜
|
|
🐜
|
In Newly Diagnosed Diffuse Large B-Cell Lymphoma, Determination of Bone Marrow Involvement with 18F-FDG PET/CT Provides Better Diagnostic Performance and Prognostic Stratification Than Does Biopsy
10 auth.
L. Berthet,
A. Cochet,
S. Kanoun,
A. Berriolo-Riedinger,
O. Humbert,
M. Toubeau,
...
I. Dygai-Cochet,
C. Legouge,
O. Casasnovas,
F. Brunotte
|
7 |
2013 |
7
🐜
|
|
🐜
|
Baseline metabolic tumour volume is an independent prognostic factor in Hodgkin lymphoma
10 auth.
S. Kanoun,
C. Rossi,
A. Berriolo-Riedinger,
I. Dygai-Cochet,
A. Cochet,
O. Humbert,
...
M. Toubeau,
E. Ferrant,
F. Brunotte,
R. Casasnovas
|
7 |
2014 |
7
🐜
|
|
🐬
|
18F-FDG PET/CT for Staging and Restaging of Breast Cancer
D. Groheux,
A. Cochet,
O. Humbert,
J. Alberini,
E. Hindié,
D. Mankoff
|
7 |
2016 |
7
🐬
|
|
🐢
|
Influence of Software Tool and Methodological Aspects of Total Metabolic Tumor Volume Calculation on Baseline [18F]FDG PET to Predict Survival in Hodgkin Lymphoma
11 auth.
S. Kanoun,
Ilan Tal,
A. Berriolo-Riedinger,
C. Rossi,
J. Riedinger,
J. Vrigneaud,
...
L. Legrand,
O. Humbert,
O. Casasnovas,
F. Brunotte,
A. Cochet
|
6 |
2015 |
6
🐢
|
|
🐜
|
Changes in 18F-FDG tumor metabolism after a first course of neoadjuvant chemotherapy in breast cancer: influence of tumor subtypes.
9 auth.
O. Humbert,
A. Berriolo-Riedinger,
J. Riedinger,
B. Coudert,
L. Arnould,
A. Cochet,
...
C. Loustalot,
P. Fumoleau,
F. Brunotte
|
6 |
2012 |
6
🐜
|
|
🦁
|
Major prognostic impact of persistent microvascular obstruction as assessed by contrast-enhanced cardiac magnetic resonance in reperfused acute myocardial infarction
10 auth.
A. Cochet,
L. Lorgis,
A. Lalande,
M. Zeller,
J. Beer,
P. Walker,
...
C. Touzery,
J. Wolf,
F. Brunotte,
Y. Cottin
|
6 |
2009 |
6
🦁
|
|
🦁
|
18F-FDG PET/CT provides powerful prognostic stratification in the primary staging of large breast cancer when compared with conventional explorations
11 auth.
A. Cochet,
I. Dygai-Cochet,
J. Riedinger,
O. Humbert,
A. Berriolo-Riedinger,
M. Toubeau,
...
S. Guiu,
C. Coutant,
B. Coudert,
P. Fumoleau,
F. Brunotte
|
6 |
2014 |
6
🦁
|
